oncology Archives - Express Pharma

Large pharma drug licensing from China reaches record high at 28 per cent in 2024, reveals GlobalData

Belgian Economic Mission to India highlights collaborations in lifesciences sector

VeGen Labs secures BIRAC funding to advance KRAS Inhibitor

Zydus Lifesciences signs agreement with Synthon BV for 505(B)(2) oncology product

Ichnos Glenmark Innovation presents first clinical data from phase 1 study of Trispecific TREAT Antibody, ISB 2001

Sun Pharma and Philogen sign global licensing agreement for Fibromun

Lupin launches Doxorubicin Hydrochloride Liposome Injection in the United States

Our aim is to tailor our oncology portfolio to address the most pressing needs in India

AstraZeneca sets $80 billion revenue target by 2030

Alembic Pharmaceuticals receives an EIR for its oncology formulation facility